Phase I and pharmacologic study of liposomal lurtotecan (NX 211): Urinary Excretion predicts hematologic toxicity

D Kehrer, AM Bos, Jaap Verweij, HJ Groen, Walter Loos, A Sparreboom, Maja de Jonge, M Hamilton, T Cameron, EGE de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1222-1231
Number of pages10
JournalJournal of Clinical Oncology
Issue number5
Publication statusPublished - 2002

Cite this